Liberum Capital reiterated their buy rating on shares of Reckitt Benckiser Group (LON:RB) in a research report report published on Thursday morning, ThisIsMoney.Co.Uk reports.

A number of other research firms have also recently commented on RB. Shore Capital restated a house stock rating on shares of in a research report on Wednesday, June 12th. Goldman Sachs Group set a GBX 6,870 ($89.77) target price on Reckitt Benckiser Group and gave the company a neutral rating in a research report on Tuesday, June 25th. Royal Bank of Canada cut 3M from an outperform rating to a sector perform rating and dropped their target price for the company from $207.00 to $176.00 in a research report on Monday, July 8th. Credit Suisse Group restated a hold rating on shares of FactSet Research Systems in a research report on Monday, July 8th. Finally, Morgan Stanley restated an overweight rating on shares of in a research report on Thursday, June 20th. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and twelve have given a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus price target of GBX 7,211.11 ($94.23).

LON:RB opened at GBX 6,595 ($86.18) on Thursday. Reckitt Benckiser Group has a 52 week low of GBX 5,559 ($72.64) and a 52 week high of GBX 7,174 ($93.74). The company has a debt-to-equity ratio of 80.49, a current ratio of 0.65 and a quick ratio of 0.47. The firm has a market cap of $46.76 billion and a PE ratio of 21.64. The company’s 50-day simple moving average is GBX 6,384.22.

In other news, insider Andrew R. J. Bonfield acquired 146 shares of the stock in a transaction that occurred on Tuesday, May 21st. The shares were bought at an average cost of GBX 6,290 ($82.19) per share, for a total transaction of £9,183.40 ($11,999.74). Also, insider Adrian Nevil Hennah sold 13,701 shares of Reckitt Benckiser Group stock in a transaction dated Friday, May 10th. The stock was sold at an average price of GBX 6,143 ($80.27), for a total value of £841,652.43 ($1,099,767.97).

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Story: How are the companies in the S&P 500 selected?

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.